# FDA Inspection 1273612 - Merck Sante - September 23, 2022

Source: https://www.keypedia.com/records/fda_inspections/merck-sante/c3c5ed05-c5f0-4616-8468-0e0c5dd7bd0a
Source feed: FDA_Inspections

> FDA Inspection 1273612 for Merck Sante on September 23, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1273612
- Company Name: Merck Sante
- Inspection Date: 2022-09-23
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1065147 - 2018-07-11](https://www.keypedia.com/records/fda_inspections/merck-sante/6969c29e-7f30-4647-a20e-4a5bd6e3a43b)
- [FDA Inspection 878778 - 2014-04-03](https://www.keypedia.com/records/fda_inspections/merck-sante/529ad265-34a6-4991-9500-dc5d026f7594)
- [FDA Inspection 659967 - 2010-04-09](https://www.keypedia.com/records/fda_inspections/merck-sante/f4958e8a-f40d-4549-b9ed-c87d2c4b094c)

Company: https://www.keypedia.com/companies/merck-sante/688f7e79-72f9-44e7-bcae-b86aac1643b1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c